300181.SZ
佐力药业
SZSE · Healthcare · C 制造业 · CN
CNY 13.98
−1.20%Margins
Gross margin
62.4%
EBITDA margin
27.2%
EBIT margin
25.3%
Net margin
20.9%
FCF margin
11.4%
19.0%
Return on equity
12.2%
Return on assets
18.8%
Return on invested capital
0.62x
Asset turnover
CNY 569.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026